المؤلفون: Narayanan N; Department of Pharmacy Practice and Administration, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey, USA., Mathers AJ; Department of Medicine and Pathology, University of Virginia, Charlottesville, Virginia, USA., Wenzler E; Roche Diagnostics Corporation, Indianapolis, Indiana, USA., Moore NM; Departments of Internal Medicine and Pathology, Rush University Medical Center, Chicago, Illinois, USA., Giske CG; Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska University Hospital and Karolinska Institute, Stockholm, Sweden., Mendes RE; JMI Laboratories, North Liberty, Iowa, USA., Edelstein PH; Department Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.; Department of Medicine, Molecular Immunity Unit, Cambridge Institute of Therapeutic Immunology and Infectious Diseases, University of Cambridge, Cambridge, United Kingdom.

المصدر: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Aug 16; Vol. 79 (2), pp. 516-523.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE

مواضيع طبية MeSH: Microbial Sensitivity Tests*/standards , Anti-Bacterial Agents*/pharmacology , Anti-Bacterial Agents*/therapeutic use , Enterobacteriaceae*/drug effects , Amoxicillin-Potassium Clavulanate Combination*/pharmacology , Amoxicillin-Potassium Clavulanate Combination*/therapeutic use, Humans ; Enterobacteriaceae Infections/drug therapy ; Enterobacteriaceae Infections/microbiology

المؤلفون: Alou L, Gómez-Rubio E, Giménez Mestre MJ, Alvaro-Afonso FJ, Coronel P; Pilar Coronel, PhD, Scientific Department, Meiji Pharma Spain, Alcalá de Henares, Avda. de Madrid, 94, Alcalá de Henares, Madrid, 28802, Spain. p.coronel@meiji.e., Sevillano D

المصدر: Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia [Rev Esp Quimioter] 2024 Aug; Vol. 37 (4), pp. 356-359. Date of Electronic Publication: 2024 Jun 13.

نوع المنشور: Journal Article; Comparative Study

بيانات الدورية: Publisher: Sociedad Española de Quimioterapia Country of Publication: Spain NLM ID: 9108821 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1988-9518 (Electronic) Linking ISSN: 02143429 NLM ISO Abbreviation: Rev Esp Quimioter Subsets: MEDLINE

مواضيع طبية MeSH: Diabetic Foot*/drug therapy , Diabetic Foot*/microbiology , Anti-Bacterial Agents*/therapeutic use , Amoxicillin-Potassium Clavulanate Combination*/therapeutic use , Cephalosporins*/therapeutic use , Microbial Sensitivity Tests*, Humans ; Streptococcus/drug effects ; Soft Tissue Infections/drug therapy ; Soft Tissue Infections/microbiology ; Male ; Female ; Staphylococcus/drug effects ; Middle Aged

المؤلفون: Freundt-Serpa NP; Allergy Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos -IdISSC, Madrid, Spain.; Allergy Research Group, IdISSC, Madrid, Spain., Salas-Cassinello M; Allergy Unit, Hospital Regional Universitario de Málaga, Málaga, Spain.; Allergy Research Group, Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain., Gonzalo-Fernández A; Allergy Research Group, IdISSC, Madrid, Spain., Marchán-Pinedo N; Allergy Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos -IdISSC, Madrid, Spain.; Allergy Research Group, IdISSC, Madrid, Spain., Doña I; Allergy Unit, Hospital Regional Universitario de Málaga, Málaga, Spain.; Allergy Research Group, Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain., Serrano-García I; Unidad de Apoyo Metodológico a la Investigación (UAMI), IdISSC, Madrid, Spain., Humanes-Navarro AM; Preventive Medicine and Public Health Department, Hospital Clínico San Carlos, IdISSC, Madrid, Spain., Bogas G; Allergy Unit, Hospital Regional Universitario de Málaga, Málaga, Spain.; Allergy Research Group, Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain., Labella M; Allergy Unit, Hospital Regional Universitario de Málaga, Málaga, Spain.; Allergy Research Group, Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain., Sánchez-Morillas L; Allergy Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos -IdISSC, Madrid, Spain.; Allergy Research Group, IdISSC, Madrid, Spain., Torres MJ; Allergy Unit, Hospital Regional Universitario de Málaga, Málaga, Spain.; Allergy Research Group, Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain.; Nanostructures for Diagnosing and Treatment of Allergic Diseases Laboratory, Andalusian Center for Nanomedicine and Biotechnology- BIONAND, Málaga, Spain.; Departamento de Medicina, Universidad de Málaga, Málaga, Spain., Fernández-Rivas M; Allergy Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos -IdISSC, Madrid, Spain.; Allergy Research Group, IdISSC, Madrid, Spain.; Facultad de Medicina, Universidad Complutense de Madrid, Málaga, Spain.

المصدر: Journal of investigational allergology & clinical immunology [J Investig Allergol Clin Immunol] 2024 Jun 17; Vol. 34 (3), pp. 177-187. Date of Electronic Publication: 2023 Feb 23.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Esmon Publicidad Country of Publication: Spain NLM ID: 9107858 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1018-9068 (Print) Linking ISSN: 10189068 NLM ISO Abbreviation: J Investig Allergol Clin Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Drug Hypersensitivity*/diagnosis , Drug Hypersensitivity*/epidemiology , Drug Hypersensitivity*/etiology , Amoxicillin-Potassium Clavulanate Combination*/adverse effects , Amoxicillin-Potassium Clavulanate Combination*/immunology, Humans ; Female ; Male ; Middle Aged ; Cross-Sectional Studies ; Retrospective Studies ; Adult ; Aged ; Anti-Bacterial Agents/adverse effects ; Anti-Bacterial Agents/immunology ; Spain/epidemiology ; Time Factors ; Hypersensitivity, Immediate/diagnosis ; Hypersensitivity, Immediate/epidemiology ; Hypersensitivity, Delayed/diagnosis

عنوان ترانسليتريتد: Severe hepatic cholestasis after treatment with amoxicillin/clavulanic acid.

المؤلفون: Meier M; Mave- og Tarmkirurgisk Afdeling, Regionshospitalet Randers.; Mave- og Tarmkirurgisk Afdeling, Aarhus Universitetshospital., Eriksen PL; Medicinsk Afdeling, Regionshospitalet Randers.; Lever-, Mave- og Tarmsygdomme, Aarhus Universitetshospital.

المصدر: Ugeskrift for laeger [Ugeskr Laeger] 2024 May 20; Vol. 186 (21). Date of Electronic Publication: 2024 May 20.

نوع المنشور: Case Reports; English Abstract; Journal Article

بيانات الدورية: Publisher: Den Alm Danske Laegerforening Country of Publication: Denmark NLM ID: 0141730 Publication Model: Electronic Cited Medium: Internet ISSN: 1603-6824 (Electronic) Linking ISSN: 00415782 NLM ISO Abbreviation: Ugeskr Laeger Subsets: MEDLINE

مواضيع طبية MeSH: Amoxicillin-Potassium Clavulanate Combination*/adverse effects , Amoxicillin-Potassium Clavulanate Combination*/therapeutic use , Chemical and Drug Induced Liver Injury*/etiology , Anti-Bacterial Agents*/adverse effects , Anti-Bacterial Agents*/therapeutic use, Humans ; Female ; Aged, 80 and over ; Fatal Outcome ; Cholestasis, Intrahepatic/chemically induced

المؤلفون: Román-Sagüillo S; Instituto Universitario de Biomedicina (IBIOMED), Universidad de León, 24071 León, Spain., Quiñones Castro R; Servicio de Aparato Digestivo, Complejo Asistencial Universitario de León, 24008 León, Spain., Juárez-Fernández M; Instituto Universitario de Biomedicina (IBIOMED), Universidad de León, 24071 León, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, 28029 Madrid, Spain., Soluyanova P; Unidad Mixta de Investigación en Hepatología Experimental, IIS Hospital La Fe, 46026 Valencia, Spain.; Departamento de Bioquímica y Biología Molecular, Universidad de Valencia, 46010 Valencia, Spain., Stephens C; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, 28029 Madrid, Spain.; Unidad de Gestión Clínica de Aparato Digestivo y Servicio de Farmacología Clínica, Instituto de Investigación Biomédica de Málaga-IBIMA Plataforma BIONAND, Hospital Universitario Virgen de la Victoria, Facultad de Medicina, Universidad de Málaga, 29010 Málaga, Spain., Robles-Díaz M; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, 28029 Madrid, Spain.; Unidad de Gestión Clínica de Aparato Digestivo y Servicio de Farmacología Clínica, Instituto de Investigación Biomédica de Málaga-IBIMA Plataforma BIONAND, Hospital Universitario Virgen de la Victoria, Facultad de Medicina, Universidad de Málaga, 29010 Málaga, Spain., Jorquera Plaza F; Instituto Universitario de Biomedicina (IBIOMED), Universidad de León, 24071 León, Spain.; Servicio de Aparato Digestivo, Complejo Asistencial Universitario de León, 24008 León, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, 28029 Madrid, Spain., González-Gallego J; Instituto Universitario de Biomedicina (IBIOMED), Universidad de León, 24071 León, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, 28029 Madrid, Spain., Martínez-Flórez S; Instituto Universitario de Biomedicina (IBIOMED), Universidad de León, 24071 León, Spain., García-Mediavilla MV; Instituto Universitario de Biomedicina (IBIOMED), Universidad de León, 24071 León, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, 28029 Madrid, Spain., Nistal E; Instituto Universitario de Biomedicina (IBIOMED), Universidad de León, 24071 León, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, 28029 Madrid, Spain., Jover R; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, 28029 Madrid, Spain.; Unidad Mixta de Investigación en Hepatología Experimental, IIS Hospital La Fe, 46026 Valencia, Spain.; Departamento de Bioquímica y Biología Molecular, Universidad de Valencia, 46010 Valencia, Spain., Sánchez-Campos S; Instituto Universitario de Biomedicina (IBIOMED), Universidad de León, 24071 León, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, 28029 Madrid, Spain.

المصدر: International journal of molecular sciences [Int J Mol Sci] 2024 Jun 22; Vol. 25 (13). Date of Electronic Publication: 2024 Jun 22.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

مواضيع طبية MeSH: Gastrointestinal Microbiome*/drug effects , Feces*/microbiology , Bile Acids and Salts*/metabolism , Amoxicillin-Potassium Clavulanate Combination*/adverse effects , Chemical and Drug Induced Liver Injury*/metabolism , Chemical and Drug Induced Liver Injury*/etiology , Metabolome*/drug effects, Humans ; Male ; Female ; Middle Aged ; Adult ; Aged

المؤلفون: Wei J; Nuffield Department of Medicine, University of Oxford, Oxford, UK., Uppal A; Nuffield Department of Medicine, University of Oxford, Oxford, UK., Nganjimi C; Department of Engineering Science, University of Oxford, Oxford, UK., Warr H; Department of Engineering Science, University of Oxford, Oxford, UK., Ibrahim Y; Department of Engineering Science, University of Oxford, Oxford, UK., Gu Q; Nuffield Department of Medicine, University of Oxford, Oxford, UK., Yuan H; Big Data Institute, Nuffield Department of Population Health, University of Oxford, Oxford, UK., Rahman NM; Nuffield Department of Medicine, University of Oxford, Oxford, UK; Oxford Centre for Respiratory Medicine, Churchill Hospital, Oxford, UK; The National Institute for Health Research Oxford Biomedical Research Centre, University of Oxford, Oxford, UK., Jones N; Department of Infectious Diseases and Microbiology, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK., Walker AS; Nuffield Department of Medicine, University of Oxford, Oxford, UK; The National Institute for Health Research Oxford Biomedical Research Centre, University of Oxford, Oxford, UK; The National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford, Oxford, UK., Eyre DW; Big Data Institute, Nuffield Department of Population Health, University of Oxford, Oxford, UK; The National Institute for Health Research Oxford Biomedical Research Centre, University of Oxford, Oxford, UK; Department of Infectious Diseases and Microbiology, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK; The National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford, Oxford, UK. Electronic address: david.eyre@bdi.ox.ac.uk.

المصدر: The Journal of infection [J Infect] 2024 Jun; Vol. 88 (6), pp. 106161. Date of Electronic Publication: 2024 Apr 23.

نوع المنشور: Journal Article; Comparative Study

بيانات الدورية: Publisher: W.B. Saunders Country of Publication: England NLM ID: 7908424 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-2742 (Electronic) Linking ISSN: 01634453 NLM ISO Abbreviation: J Infect Subsets: MEDLINE

مواضيع طبية MeSH: Community-Acquired Infections*/drug therapy , Community-Acquired Infections*/mortality , Amoxicillin*/therapeutic use , Anti-Bacterial Agents*/therapeutic use , Amoxicillin-Potassium Clavulanate Combination*/therapeutic use, Humans ; Male ; Female ; Aged ; Middle Aged ; United Kingdom/epidemiology ; Hospitalization/statistics & numerical data ; Aged, 80 and over ; Adult ; Pneumonia/mortality ; Pneumonia/drug therapy ; Treatment Outcome ; Retrospective Studies ; Pneumonia, Bacterial/drug therapy ; Pneumonia, Bacterial/mortality

المؤلفون: Karpishchenko SA; Pavlov First Saint Petersburg State Medical University., Ryabova MА; Pavlov First Saint Petersburg State Medical University., Kolesnikova OM; Pavlov First Saint Petersburg State Medical University., Ulupov MY; Pavlov First Saint Petersburg State Medical University.

المصدر: Terapevticheskii arkhiv [Ter Arkh] 2024 Apr 16; Vol. 96 (3), pp. 273-279. Date of Electronic Publication: 2024 Apr 16.

نوع المنشور: Journal Article; Randomized Controlled Trial; Comparative Study; English Abstract

بيانات الدورية: Publisher: ZAO 'Konsilium Medikum Country of Publication: Russia (Federation) NLM ID: 2984818R Publication Model: Electronic Cited Medium: Print ISSN: 0040-3660 (Print) Linking ISSN: 00403660 NLM ISO Abbreviation: Ter Arkh Subsets: MEDLINE

مواضيع طبية MeSH: Streptococcal Infections*/drug therapy , Streptococcal Infections*/microbiology , Pharyngitis*/drug therapy , Pharyngitis*/microbiology , Anti-Bacterial Agents*/administration & dosage , Anti-Bacterial Agents*/pharmacology , Tonsillitis*/drug therapy , Tonsillitis*/microbiology , Amoxicillin-Potassium Clavulanate Combination*/administration & dosage, Humans ; Male ; Female ; Adult ; Acute Disease ; Treatment Outcome ; Middle Aged

المؤلفون: Naya Ríos L; Servicio de Neurología, Complejo Hospitalario Universitario de A Coruña, A Coruña, Spain. Electronic address: Lucia.Naya.Rios@sergas.es., Santos García D; Servicio de Neurología, Complejo Hospitalario Universitario de A Coruña, A Coruña, Spain., Cores Bartalomé C; Servicio de Neurología, Complejo Hospitalario Universitario de A Coruña, A Coruña, Spain., Docampo Carro I; Servicio de Urgencias, Complejo Hospitalario Universitario de A Coruña, A Coruña, Spain.

المصدر: Neurologia [Neurologia (Engl Ed)] 2024 Apr; Vol. 39 (3), pp. 312-314. Date of Electronic Publication: 2024 Feb 20.

نوع المنشور: Letter

بيانات الدورية: Publisher: Elsevier España Country of Publication: Spain NLM ID: 101778590 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2173-5808 (Electronic) Linking ISSN: 21735808 NLM ISO Abbreviation: Neurologia (Engl Ed) Subsets: MEDLINE

مواضيع طبية MeSH: Amoxicillin-Potassium Clavulanate Combination*/adverse effects , Serotonin Syndrome*/chemically induced , Serotonin Syndrome*/drug therapy, Humans ; Anti-Bacterial Agents/adverse effects

المؤلفون: Verma D; International Graduate Program of Nanoscience and Technology, Graduate School, Chulalongkorn University, Bangkok, 10330, Thailand., Okhawilai M; International Graduate Program of Nanoscience and Technology, Graduate School, Chulalongkorn University, Bangkok, 10330, Thailand; Metallurgy and Materials Science Research Institute, Chulalongkorn University, Bangkok, 10330, Thailand; Center of Excellence in Polymeric Materials for Medical Practice Devices, Department of Chemical Engineering, Faculty of Engineering, Chulalongkorn University, Bangkok, 10330, Thailand. Electronic address: Manunya.o@chula.ac.th., Senthilkumar N; Metallurgy and Materials Science Research Institute, Chulalongkorn University, Bangkok, 10330, Thailand., Subramani K; Department of Biochemistry, Faculty of Science, Chulalongkorn University, Bangkok, 10330, Thailand., Incharoensakdi A; Department of Biochemistry, Faculty of Science, Chulalongkorn University, Bangkok, 10330, Thailand; Academy of Science, Royal Society of Thailand, Bangkok, 10300, Thailand., Raja GG; Instituto de Alta Investigación, Universidad de Tarapacá, Arica, 1000000, Chile., Uyama H; Department of Applied Chemistry, Graduate School of Engineering, Osaka University, Osaka, 565-0871, Japan.

المصدر: Environmental research [Environ Res] 2024 Feb 01; Vol. 242, pp. 117811. Date of Electronic Publication: 2023 Dec 01.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 0147621 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-0953 (Electronic) Linking ISSN: 00139351 NLM ISO Abbreviation: Environ Res Subsets: MEDLINE

مواضيع طبية MeSH: Amoxicillin-Potassium Clavulanate Combination* , Nanotubes*/chemistry , Sulfuric Acids*, Clay/chemistry ; Spectroscopy, Fourier Transform Infrared ; Staphylococcus aureus ; Escherichia coli ; Anti-Bacterial Agents/pharmacology

المؤلفون: Savage TJ; Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, Massachusetts., Kronman MP; Division of Infectious Diseases, Seattle Children's Hospital, Seattle, Washington., Huybrechts KF; Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, Massachusetts.

المصدر: JAMA [JAMA] 2024 Jan 16; Vol. 331 (3), pp. 258-259.

نوع المنشور: Letter; Comment

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN: 1538-3598 (Electronic) Linking ISSN: 00987484 NLM ISO Abbreviation: JAMA Subsets: MEDLINE

مواضيع طبية MeSH: Amoxicillin*/therapeutic use , Amoxicillin-Potassium Clavulanate Combination*/therapeutic use , Anti-Bacterial Agents*/therapeutic use , Sinusitis*/drug therapy, Child ; Humans ; Acute Disease ; Drug Combinations